MarketLens
Sign Up

Why is Cathie Wood Shifting from Tech to Biotech

6 months ago
SHARE THIS ON:

Why is Cathie Wood Shifting from Tech to Biotech

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News4 weeks ago

Why Are Small-Cap ETFs Outperforming?

Small-cap ETFs are outperforming large caps this year, reversing years of mega-cap tech dominance, as investors shift toward smaller companies.
Stock News1 months ago

Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead?

Beam Therapeutics' expanding pipeline may reward patient investors, per Cathie Wood's recent purchase. The biotech's base-editing platform targets multiple genetic diseases.
Stock News1 months ago

Why Pure-Play Healthcare Technology Innovation Matters

The ROBO Global Healthcare Technology and Innovation ETF (HTEC) offers targeted exposure to the global healthcare innovation value chain, as portfolios are commonly underexposed to this high-growth op...

Breaking News

View All →

Top Headlines

View More →
Stock News34 minutes ago

Dell Reports Record Results: AI Momentum Remains Robust

Stock News53 minutes ago

Nvidia: Betting Against AI's Landlord Is A Widow-Maker Trade

Stock News56 minutes ago

Not just Nvidia: these power and cooling firms are riding the trillion-dollar data centre boom

Stock News1 hour ago

Dell is printing 'shock and awe' numbers, says Evercore's Amit Daryanani

Stock News1 hour ago

Dell Technologies (DELL) Q2 Earnings and Revenues Top Estimates